Metabolic profiling of aortic stenosis and hypertrophic cardiomyopathy identifies mechanistic contrasts in substrate utilization
Journal article
Pal N. et al, (2024), FASEB Journal, 38
Promoter Deletion Confirms That MYBPC3 Haploinsufficiency Is Sufficient to Cause Hypertrophic Cardiomyopathy in Humans.
Journal article
Hayesmoore JBG. et al, (2024), Circ Genom Precis Med
Genotype-Phenotype Taxonomy of Hypertrophic Cardiomyopathy.
Journal article
Curran L. et al, (2023), Circ Genom Precis Med
Structural and non-coding variants increase the diagnostic yield of clinical whole genome sequencing for rare diseases.
Journal article
Pagnamenta AT. et al, (2023), Genome Med, 15
The penetrance of rare variants in cardiomyopathy-associated genes: A cross-sectional approach to estimating penetrance for secondary findings.
Journal article
McGurk KA. et al, (2023), Am J Hum Genet, 110, 1482 - 1495
GWAS of random glucose in 476,326 individuals provide insights into diabetes pathophysiology, complications and treatment stratification.
Journal article
Lagou V. et al, (2023), Nat Genet, 55, 1448 - 1461
Aficamten for Drug-Refractory Severe Obstructive Hypertrophic Cardiomyopathy in Patients Receiving Disopyramide: REDWOOD-HCM Cohort 3.
Journal article
Owens AT. et al, (2023), J Card Fail
Comparing the effects of chemical Ca2+ dyes and R-GECO on contractility and Ca2+ transients in adult and human iPSC cardiomyocytes.
Journal article
Robinson P. et al, (2023), J Mol Cell Cardiol
Novel insights into diminished cardiac reserve in non-obstructive hypertrophic cardiomyopathy from four-dimensional flow cardiac magnetic resonance component analysis.
Journal article
Ashkir Z. et al, (2023), Eur Heart J Cardiovasc Imaging
Genetic Determinants of the Interventricular Septum Are Linked to Ventricular Septal Defects and Hypertrophic Cardiomyopathy
Journal article
Yu M. et al, (2023), Circulation: Genomic and Precision Medicine
Genetic architecture of spatial electrical biomarkers for cardiac arrhythmia and relationship with cardiovascular disease.
Journal article
Young WJ. et al, (2023), Nature communications, 14
Insights into the Role of a Cardiomyopathy-Causing Genetic Variant in ACTN2
Journal article
Broadway-Stringer S. et al, (2023), Cells
Loci for insulin processing and secretion provide insight into type 2 diabetes risk.
Journal article
Broadaway KA. et al, (2023), Am J Hum Genet, 110, 284 - 299
Proteomic profiling identifies novel independent relationships between inflammatory proteins and myocardial infarction.
Journal article
Valdes-Marquez E. et al, (2023), Eur J Prev Cardiol
Apolipoprotein Proteomics for Residual Lipid-Related Risk in Coronary Heart Disease.
Journal article
Clarke R. et al, (2023), Circ Res
Genome-Wide Analysis of Left Ventricular Maximum Wall Thickness in the UK Biobank Cohort Reveals a Shared Genetic Background With Hypertrophic Cardiomyopathy.
Journal article
Aung N. et al, (2023), Circ Genom Precis Med
Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy.
Journal article
Maron MS. et al, (2023), J Am Coll Cardiol, 81, 34 - 45
Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants.
Journal article
Aragam KG. et al, (2022), Nat Genet
Left ventricular anatomy in obstructive hypertrophic cardiomyopathy: beyond basal septal hypertrophy.
Journal article
Hermida U. et al, (2022), Eur Heart J Cardiovasc Imaging
Gene Sequencing Identifies Perturbation in Nitric Oxide Signaling as a Nonlipid Molecular Subtype of Coronary Artery Disease
Journal article
Khera AV. et al, (2022), Circulation: Genomic and Precision Medicine